Characterization of GI toxicities and their impact on efficacy in patients (pts) with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) treated with mobocertinib (TAK-788) who previously received platinum chemotherapy Meeting Abstract


Authors: Nguyen, D.; Ramalingam, S. S.; Spira, A.; Riely, G. J.; Kim, T. M.; Yang, J. C. H.; Piotrowska, Z.; Garcia Campelo, M. R.; Felip, E.; Bazhenova, L.; Jin, S.; Griffin, C.; Diderichsen, P. M.; Gupta, N.; Bunn, V.; Lin, J.; Churchill, E. N.; Mehta, M.; Zhou, C.; Janne, P. A.
Abstract Title: Characterization of GI toxicities and their impact on efficacy in patients (pts) with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) treated with mobocertinib (TAK-788) who previously received platinum chemotherapy
Meeting Title: ESMO Congress 2021
Journal Title: Annals of Oncology
Volume: 32
Issue: Suppl. 5
Meeting Dates: 2021 Sep 16-21
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2021-09-01
Start Page: S968
End Page: S969
Language: English
ACCESSION: WOS:000700527702236
DOI: 10.1016/j.annonc.2021.08.1823
PROVIDER: wos
Notes: Meeting Abstract #1218P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gregory J Riely
    599 Riely